AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36321244 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl-cysteine (NAC)
Number of subjects: 30
Study 36321244 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha lipoic acid (ALA)
Number of subjects: 30
Study 36321244 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of NAC + ALA
Number of subjects: 30
Study 36321244 — intervention group
Group type: COMPARATOR
Intervention: Sperm freezing medium (SFM)
Number of subjects: 30
Study 33119057 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory threshold and odor identification tests using 'Sniffin' Sticks' and 'U‐Sniff'
Number of subjects: 200
Study 32763435 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramp-up mode of the Dentapen electronic syringe
Number of subjects: 116
Study 32763435 — intervention group
Group type: COMPARATOR
Intervention: Continuous mode of the Dentapen electronic syringe
Number of subjects: 116
Study 35614169 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine OUD screening implementation
Number of subjects: 10
Study 35614169 — intervention group
Group type: EXPERIMENTAL
Intervention: Promising implementation strategies
Number of subjects: 10
Study 36279833 — intervention group
Group type: EXPERIMENTAL
Intervention: MILO (Motivational Interviewing for Loved Ones) intervention
Number of subjects: 40
Study 33694027 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrodynamic transalveolar approach (HTA)
Number of subjects: 22
Study 33694027 — intervention group
Group type: COMPARATOR
Intervention: Lateral window technique (LW)
Number of subjects: 22
Study 32160915 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol succinate
Number of subjects: 0
Study 35099626 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosquito mesh (MM)
Number of subjects: 62
Study 35099626 — intervention group
Group type: COMPARATOR
Intervention: Conventional polypropylene mesh (CM)
Number of subjects: 62
Study 33678179 — intervention group
Group type: EXPERIMENTAL
Intervention: PACE Steps to Success palliative care program
Number of subjects: 459
Study 33678179 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 459
Study 32238992 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive oral healthcare including oral health examinations, oral health education for children and their guardians, local fluoride application and dental treatment
Number of subjects: 398
Study 32238992 — intervention group
Group type: COMPARATOR
Intervention: Oral health examinations twice a year
Number of subjects: 398
Study 32238992 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive oral healthcare measures
Number of subjects: 398
Study 34806793 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-lowering interventions (metformin, dapagliflozin, or exercise)
Number of subjects: 0
Study 34806793 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32496835 — intervention group
Group type: EXPERIMENTAL
Intervention: Person-centred care
Number of subjects: 42
Study 32496835 — intervention group
Group type: COMPARATOR
Intervention: Control conditions (not specified)
Number of subjects: 42
Study 34473249 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rhythm control therapy (antiarrhythmic drugs and AF ablation)
Number of subjects: 2790
Study 34473249 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 2790
Study 34473249 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rhythm control therapy
Number of subjects: 2790
Study 34469706 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 days of intravenous antimicrobials
Number of subjects: 982
Study 34469706 — intervention group
Group type: COMPARATOR
Intervention: 14 days of intravenous antimicrobials
Number of subjects: 982
Study 34469706 — intervention group
Group type: COMPARATOR
Intervention: 21 days of intravenous antimicrobials
Number of subjects: 982
Study 34404592 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintaining serum potassium at ≥3.6 mEq/L
Number of subjects: 160
Study 34404592 — intervention group
Group type: COMPARATOR
Intervention: Maintaining serum potassium at ≥4.5 mEq/L
Number of subjects: 160
Study 34807255 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional education plus VR videos
Number of subjects: 346
Study 34807255 — intervention group
Group type: COMPARATOR
Intervention: Conventional education
Number of subjects: 346
Study 34496147 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous-intensity exercise (74 ± 9% V˙ O2peak)
Number of subjects: 13
Study 34496147 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (52 ± 5% V˙ O2peak)
Number of subjects: 13
Study 34496147 — intervention group
Group type: EXPERIMENTAL
Intervention: Both exercise intensities
Number of subjects: 13
Study 34496147 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous exercise
Number of subjects: 13
Study 32302308 — intervention group
Group type: EXPERIMENTAL
Intervention: CETA
Number of subjects: 248
Study 32302308 — intervention group
Group type: COMPARATOR
Intervention: TAU-Plus
Number of subjects: 248
Study 32194098 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month structured peer-support lifestyle intervention program involving 15 group sessions and linked community activities
Number of subjects: 1007
Study 32194098 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1007
Study 33550448 — intervention group
Group type: EXPERIMENTAL
Intervention: Lyophilized PRP
Number of subjects: 19
Study 33550448 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (Control)
Number of subjects: 19
Study 33742291 — intervention group
Group type: EXPERIMENTAL
Intervention: Common bile duct (CBD) stenting after ERCP
Number of subjects: 40
Study 33742291 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic treatment without stenting (Control Group B)
Number of subjects: 40
Study 33636145 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenotype A (n=2667): 30-day mortality rate 2.5% (95% CI 1.4–4.3)
Number of subjects: 4035
Study 33636145 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenotype B (n=2667): 30-day mortality rate 30.5% (95% CI 28.5–32.6)
Number of subjects: 4035
Study 33636145 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenotype C (n=2667): 30-day mortality rate 60.7% (95% CI 53.7–67.2)
Number of subjects: 4035
Study 33636145 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal validation cohort: Phenotype A: 5.3% (95% CI 3.4–8.1), Phenotype B: 31.3% (95% CI 28.5–34.2), Phenotype C: 59.5% (95% CI 48.8–69.3)
Number of subjects: 4035
Study 33636145 — intervention group
Group type: EXPERIMENTAL
Intervention: External validation cohort: Phenotype A: 3.7% (95% CI 2.0–6.4), Phenotype B: 23.7% (95% CI 21.8–25.7), Phenotype C: 51.4% (95% CI 41.9–60.7)
Number of subjects: 4035
Study 34153102 — intervention group
Group type: EXPERIMENTAL
Intervention: AmbIGeM system (intervention group)
Number of subjects: 3240
Study 34153102 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Evaluation and Management Unit wards (post hoc analysis)
Number of subjects: 3240
Study 34153102 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3240
Study 33506805 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological treatment (ACS)
Number of subjects: 90
Study 33506805 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological treatment (PRP)
Number of subjects: 90
Study 33506805 — intervention group
Group type: COMPARATOR
Intervention: Mechanical treatment (MT)
Number of subjects: 90
Study 33506805 — intervention group
Group type: COMPARATOR
Intervention: Mechanical treatment (TT)
Number of subjects: 90
Study 33506805 — intervention group
Group type: COMPARATOR
Intervention: Physical treatment (LT)
Number of subjects: 90
Study 33506805 — intervention group
Group type: COMPARATOR
Intervention: Physical treatment (CM)
Number of subjects: 90
Study 35132029 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided GONB at the C2 vertebral level
Number of subjects: 32
Study 35132029 — intervention group
Group type: COMPARATOR
Intervention: Landmark-based GONB with sham ultrasound at the superior nuchal line
Number of subjects: 32
Study 34076382 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine using buccal infiltration
Number of subjects: 100
Study 34076382 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine using inferior alveolar nerve block
Number of subjects: 100
Study 34076382 — intervention group
Group type: COMPARATOR
Intervention: 4% articaine or 2% lidocaine
Number of subjects: 100
Study 35476650 — intervention group
Group type: EXPERIMENTAL
Intervention: RSVpreF vaccine (120 or 240 μg, with or without aluminum hydroxide)
Number of subjects: 406
Study 35476650 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 406
Study 35476650 — intervention group
Group type: EXPERIMENTAL
Intervention: RSVpreF vaccine (with aluminum hydroxide)
Number of subjects: 406
Study 35476650 — intervention group
Group type: EXPERIMENTAL
Intervention: RSVpreF vaccine (without aluminum hydroxide)
Number of subjects: 406
Study 34172080 — intervention group
Group type: EXPERIMENTAL
Intervention: Word cloud generation based on PwCM experience
Number of subjects: 79
Study 34172080 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation plan for AO Spine RECODE‐DCM PSP surveys
Number of subjects: 79
Study 36141773 — intervention group
Group type: EXPERIMENTAL
Intervention: Lentils
Number of subjects: 12
Study 36141773 — intervention group
Group type: EXPERIMENTAL
Intervention: Trahana
Number of subjects: 12
Study 36141773 — intervention group
Group type: EXPERIMENTAL
Intervention: Halva
Number of subjects: 12
Study 36141773 — intervention group
Group type: COMPARATOR
Intervention: Glucose (reference food)
Number of subjects: 12
Study 32907393 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented arm rehabilitation (27 additional hours over six weeks)
Number of subjects: 22
Study 32907393 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported self-management
Number of subjects: 22
Study 32907393 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented arm rehabilitation starting within nine weeks post-stroke
Number of subjects: 22
Study 36410835 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intensity intervention (clinicians received 50 min communication skills training)
Number of subjects: 1599
Study 36410835 — intervention group
Group type: COMPARATOR
Intervention: Lower intensity intervention (clinicians did not receive additional communication skills training)
Number of subjects: 1599
Study 36410835 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intensity intervention
Number of subjects: 1599
Study 36410835 — intervention group
Group type: COMPARATOR
Intervention: Lower intensity intervention
Number of subjects: 1599
Study 32819894 — intervention group
Group type: COMPARATOR
Intervention: Slowly expanding/evolving lesions
Number of subjects: 299
Study 32819894 — intervention group
Group type: COMPARATOR
Intervention: Non-slowly expanding/evolving lesions
Number of subjects: 299
Study 33429741 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 0
Study 33429741 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate
Number of subjects: 0
Study 32100301 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education on prevention of hand eczema
Number of subjects: 423
Study 32100301 — intervention group
Group type: COMPARATOR
Intervention: Control group (172 MWAs)
Number of subjects: 423
Study 32100301 — intervention group
Group type: COMPARATOR
Intervention: Other factors (smoking, FLG mutations)
Number of subjects: 423
Study 35662486 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone (0.2 mg bolus via PCA)
Number of subjects: 41
Study 35662486 — intervention group
Group type: COMPARATOR
Intervention: Morphine (2 mg bolus via PCA)
Number of subjects: 41
Study 35662486 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone
Number of subjects: 41
Study 35662486 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 41
Study 34073414 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory syncytial virus (RSV)
Number of subjects: 719
Study 34073414 — intervention group
Group type: EXPERIMENTAL
Intervention: Human rhino virus (HRV)
Number of subjects: 719
Study 34073414 — intervention group
Group type: EXPERIMENTAL
Intervention: Viral co-detections
Number of subjects: 719
Study 34073414 — intervention group
Group type: COMPARATOR
Intervention: Absence of RSV
Number of subjects: 719
Study 34073414 — intervention group
Group type: COMPARATOR
Intervention: Coronavirus infection
Number of subjects: 719
Study 32460989 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Number of subjects: 30
Study 32460989 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline solution
Number of subjects: 30
Study 32524889 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Exercise Program (DEP)
Number of subjects: 106
Study 32524889 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (MD)
Number of subjects: 106
Study 32524889 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Exercise Program (DEP) and Mediterranean Diet (MD)
Number of subjects: 106
Study 33317377 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing care interventions based on Integrative Nursing and the Omaha System, including group-based activities (sightseeing, picnics, theater, cinema, group education, and charity activities) for 12 weeks.
Number of subjects: 0
Study 33317377 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving standard care, details not specified.
Number of subjects: 0
Study 33478712 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibacterial envelope
Number of subjects: 6800
Study 33478712 — intervention group
Group type: COMPARATOR
Intervention: Control (no antibacterial envelope)
Number of subjects: 6800
Study 34264344 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time ultrasonography
Number of subjects: 75
Study 34264344 — intervention group
Group type: COMPARATOR
Intervention: Static ultrasonography
Number of subjects: 75
Study 34016357 — intervention group
Group type: COMPARATOR
Intervention: HA-LOW (fixed and low-intensity training sessions)
Number of subjects: 17
Study 34016357 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-HIT (RPE-regulated intermittent training sessions)
Number of subjects: 17
Study 34016357 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-LOW and HA-HIT
Number of subjects: 17
Study 32345654 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk score (162 variants) for adult type 2 diabetes
Number of subjects: 4761
Study 32345654 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-sample Mendelian randomization (MR)
Number of subjects: 4761
Study 35856777 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalcetrapib 600 mg daily
Number of subjects: 6147
Study 35856777 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6147
Study 33463734 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted liver US (Group A)
Number of subjects: 465
Study 33463734 — intervention group
Group type: COMPARATOR
Intervention: Complete upper abdominal scan (Group B)
Number of subjects: 465
Study 32182680 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular training (NMT)
Number of subjects: 66
Study 32182680 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 66
Study 36441136 — intervention group
Group type: EXPERIMENTAL
Intervention: CR + WL (Cardiac Rehabilitation plus Weight Loss program)
Number of subjects: 38
Study 36441136 — intervention group
Group type: COMPARATOR
Intervention: CR (Cardiac Rehabilitation alone)
Number of subjects: 38
Study 32919400 — intervention group
Group type: EXPERIMENTAL
Intervention: Active NeuroStar TMS monotherapy (n=48)
Number of subjects: 103
Study 32919400 — intervention group
Group type: COMPARATOR
Intervention: Sham TMS (n=55)
Number of subjects: 103
Study 32020373 — intervention group
Group type: EXPERIMENTAL
Intervention: Perseus anesthesia workstation
Number of subjects: 50
Study 32020373 — intervention group
Group type: COMPARATOR
Intervention: Fabius Plus anesthesia workstation
Number of subjects: 50
Study 34284615 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed mode SWD
Number of subjects: 159
Study 34284615 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous mode SWD
Number of subjects: 159
Study 34284615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study 34324042 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg TXA
Number of subjects: 100
Study 34324042 — intervention group
Group type: COMPARATOR
Intervention: 10 ml/kg normal saline (placebo)
Number of subjects: 100
Study 35233880 — intervention group
Group type: EXPERIMENTAL
Intervention: PartnerCARE intervention (N = 30)
Number of subjects: 60
Study 35233880 — intervention group
Group type: COMPARATOR
Intervention: Waitlist-control group (N = 30)
Number of subjects: 60
Study 33351522 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat educational video
Number of subjects: 198
Study 33351522 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 198
Study 36195819 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient transport to melanoma clinic
Number of subjects: 0
Study 36195819 — intervention group
Group type: EXPERIMENTAL
Intervention: Health system costs
Number of subjects: 0
Study 36195819 — intervention group
Group type: EXPERIMENTAL
Intervention: Out-of-pocket costs and productivity losses
Number of subjects: 0
Study 34370573 — intervention group
Group type: EXPERIMENTAL
Intervention: Taniborbactam (62.5 to 1,500 mg single doses; 250 to 750 mg every 8 hours for 10 days)
Number of subjects: 0
Study 34370573 — intervention group
Group type: EXPERIMENTAL
Intervention: Taniborbactam
Number of subjects: 0
Study 34370573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33080795 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher blood levels of iron
Number of subjects: 310999
Study 33080795 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher blood levels of copper
Number of subjects: 310999
Study 33883475 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic psychological needs and upper limb factors
Number of subjects: 236
Study 33883475 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic psychological needs
Number of subjects: 236
Study 33883475 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivation regulations
Number of subjects: 236
Study 32949787 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP followed by aPDT (aPDT group)
Number of subjects: 11
Study 32949787 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP followed by single subgingival application of 1.2 % simvastatin gel (SMV group)
Number of subjects: 11
Study 32949787 — intervention group
Group type: COMPARATOR
Intervention: SRP alone (SRP group)
Number of subjects: 11
Study 36407430 — intervention group
Group type: EXPERIMENTAL
Intervention: DCB combined with cutting balloon
Number of subjects: 140
Study 36407430 — intervention group
Group type: COMPARATOR
Intervention: Cutting balloon angioplasty
Number of subjects: 140
Study 36456006 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised heart team protocol
Number of subjects: 84
Study 36456006 — intervention group
Group type: COMPARATOR
Intervention: Guideline‐based protocol
Number of subjects: 84
Study 32546013 — intervention group
Group type: EXPERIMENTAL
Intervention: mild traumatic brain injury (mTBI)
Number of subjects: 81
Study 32546013 — intervention group
Group type: COMPARATOR
Intervention: concussion
Number of subjects: 81
Study 32032829 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-mediated intervention for children with autism
Number of subjects: 71
Study 35594542 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual pathway inhibition (DPI) using rivaroxaban 2.5 mg twice daily plus aspirin
Number of subjects: 5532
Study 35594542 — intervention group
Group type: COMPARATOR
Intervention: Control group from COMPASS trial
Number of subjects: 5532
Study 32124499 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led cognitive behavioral training (CBT) intervention; 8 sessions over 1 year; delivered in the context of diabetes self-management.
Number of subjects: 230
Study 32124499 — intervention group
Group type: COMPARATOR
Intervention: Attention control arm; peer-delivered 8-session general health education program.
Number of subjects: 230
Study 33303011 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular vaccination with routine MMR (M-M-R VaxPro)
Number of subjects: 6500
Study 33303011 — intervention group
Group type: COMPARATOR
Intervention: Placebo (solvent only)
Number of subjects: 6500
Study 33303011 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (MMR and placebo)
Number of subjects: 6500
Study 34366204 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer recovery specialist (PRS) support
Number of subjects: 76
Study 34366204 — intervention group
Group type: COMPARATOR
Intervention: Services as usual
Number of subjects: 76
Study 32546117 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensemble methods (random forest, adaptive boosting, extremely randomized trees) for QSAR model design and prediction.
Number of subjects: 0
Study 32546117 — intervention group
Group type: EXPERIMENTAL
Intervention: y-scrambling method for model validation.
Number of subjects: 0
Study 35362694 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Rehabilitation (CR) combined with a home-based exercise program
Number of subjects: 26
Study 35362694 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 26
Study 33692028 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 104
Study 33692028 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 104
Study 33692028 — intervention group
Group type: COMPARATOR
Intervention: Initially undetectable pEBV DNA
Number of subjects: 104
Study 36342781 — intervention group
Group type: EXPERIMENTAL
Intervention: Video decision aid
Number of subjects: 182
Study 36342781 — intervention group
Group type: COMPARATOR
Intervention: Verbal narratives accompanied by photos
Number of subjects: 182
Study 34605378 — intervention group
Group type: EXPERIMENTAL
Intervention: Social network sites (SNSs) training
Number of subjects: 144
Study 34605378 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle education (active control)
Number of subjects: 144
Study 34605378 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (control)
Number of subjects: 144
Study 32115853 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/day
Number of subjects: 19